Aug 8
|
Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference
|
Aug 4
|
Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial
|
Jul 30
|
Anixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology
|
Jul 25
|
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?
|
Jul 24
|
Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s
|
Jun 26
|
ANIXA BIOSCIENCES INC (ANIX) is a Great Momentum Stock: Should You Buy?
|
Jun 23
|
Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year?
|
Jun 23
|
Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
|
Jun 11
|
3 Promising Penny Stocks With Market Caps Over $100M
|
Jun 10
|
What Makes ANIXA BIOSCIENCES INC (ANIX) a Strong Momentum Stock: Buy Now?
|
Jun 10
|
Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage
|
Jun 9
|
Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025
|
May 19
|
Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones
|
Apr 14
|
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
|
Mar 10
|
Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?
|
Mar 10
|
Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
|
Mar 3
|
Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
|
Feb 27
|
Spotlight On February 2025's Promising Penny Stocks
|
Feb 26
|
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
|
Feb 25
|
Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"
|